You are going to be able to put a new therapeutic area on your resume, and get a salary for generating very very very few Savaysa prescriptions. There are probably 60,000 patients in your territory with hypertension, lots of new patients for Benicar even in the crowded market. There are about 70,000 patients in your territory with high cholesterol, even Welchol gets a nice amount of prescriptions with so many new patients. There are only about 4,000 Afib patients in your territory. Most are on Warfarin, many are on the recent NOAC products. Not many new patients and how many will even be allowed to go on your new product? But you will get experience and be able to see what happens until Benicar goes generic. Good luck.
